Full Text View
Tabular View
No Study Results Posted
Related Studies
Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis
This study has been terminated.
( Change of dose regimen (new protocol) )
Study NCT00555646   Information provided by Provectus Pharmaceuticals
First Received: November 7, 2007   Last Updated: July 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Plaque Psoriasis
Additional conditions recognized in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
PH-10 (rose bengal disodium 0.001%)
Control
Sponsors listed in this trial
Provectus Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services